CK Life Sciences International (8222.HK) Announces U.S. FDA's Clearance to Commence Phase III Clinical Testing of Melanoma Vaccine
3/6/2012 9:52:28 AM
More...
|
CK Life Sciences International (8222.HK) Increases Equity Stake in Wex Pharmaceuticals Inc. (WXIFF.PK)
10/19/2009 12:08:15 PM
More...
|
CK Life Sciences International (8222.HK) And Keith Frankel Partner To Take Vitaquest To The Next Level Of Development
2/9/2006 10:50:55 AM
More...
|
MidOcean Partners Agrees To Sell Majority Stake In Vitaquest International To CK Life Sciences International (8222.HK)
2/6/2006 12:53:42 PM
More...
|
Hong Kong CK Life Sciences International Plans A$10M Biotech R&D Spending In Australia
10/19/2005 5:11:55 PM
More...
|